What changed: Metastatic triple-negative breast cancer
Every dated change on the records linked to Metastatic triple-negative breast cancer, newest first: approvals and regulatory steps on its medicines, trials that reported, guideline versions, milestones, and when this page itself was checked. Dates come from the records; none is inferred. Orientation, not medical advice.
Trial result11Milestone8This record1
September 2026 · 1
2026 · 2
2025 · 4
- 2025Trial resultASCENT-03ASCENT-03 reported
PFS HR 0.
- 2025Trial resultASCENT-04 / KEYNOTE-D19ASCENT-04 / KEYNOTE-D19 reported
PFS HR 0.
- 2025Trial resultTROPION-Breast02TROPION-Breast02 reported
OS 23.
- 2025MilestoneASCENT-03ASCENT-03, ASCENT-04 and TROPION-Breast02 positive in the first line
A milestone in how this cancer is treated.